PaperHepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination
References (20)
- et al.
Low immune responses to hepatitis B vaccination among healthy subjects
Lancet
(1985) - et al.
Decline of antiHBs after hepatitis B vaccination and timing of revaccination
Lancet
(1990) - et al.
Timming of hepatitis B revaccination in healthy adults
Lancet
(1987) - et al.
Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBs responses were initially elicited by a plasma-derived vaccine
Vaccine
(1991) Revaccination against hepatitis B
Lancet
(1991)- et al.
Seven years study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal)
Lancet
(1986) Hepatitis B vaccination: protection for how long and against what?
Br. Med. J.
(1993)Hepatitis por virus B
Gastrum
(1989)- et al.
Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine
J. Am. Med. Assoc.
(1985) Suboptimal response to hepatitis B vaccine given by injection in the buttock
Morbid. Mortal. Wkly Rep.
(1985)
Cited by (51)
Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study
2021, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsCitation Excerpt :In addition, the positive-HBsAb group was younger, had a higher proportion of women, obese and overweight cases, as well as more recipients of a 3-dose HB vaccine, compared with negative-HBsAb participants. After adjusting for confounding factors, the results of the present study also revealed that BMI was not an independent determinant of vaccine-induced immune response among both negative and positive HBsAb titer groups; these findings are in agreement with some previous related studies [11,18–22]. Similarly, Nashibi et al. observed no considerable association between BMI and poor seroprotection following HBV vaccine among medical staff [18].
Good response to the primary course and booster dose of hepatitis B vaccine in children with non-alcoholic fatty liver disease
2017, Digestive and Liver DiseaseHepatitis B vaccine response in obesity: A meta-analysis
2016, VaccineCitation Excerpt :As the most effective means to protect people from HBV infection, the program on immunization with recombinant hepatitis B vaccine was instituted in more than 200 counties since 1982. These efforts resulted in a remarkable decrease of HBsAg positivity worldwide, especially in children and adolescents [3–6]. Obesity is a major health problem worldwide [7,8].
Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing
2015, Clinical TherapeuticsCitation Excerpt :This case report suggests that obese children may still derive benefit from this drug. Minana et al84 studied 427 children to examine hepatitis B vaccine immune response and duration of protection in obese versus normal-weight children (Table IX). There was a weak correlation between BMI and hepatitis B surface antigen antibodies; however, all children had concentrations of these antibodies above the recommended 10 IU/L.
High prevalence of hepatitis B non-immunity in paediatric non-alcoholic fatty liver disease patients
2014, Digestive and Liver Disease